CA2808210C — Tetracyclic compounds having alk inhibitory activity and compositions thereof
Assigned to Chugai Pharmaceutical Co Ltd · Expires 2019-10-01 · 7y expired
What this patent protects
A composition which comprises substance represented by Formula (I), (see formula I) a pharmaceutically acceptable carrier, and a dissolution aid useful for improving solubility, oral absorbability and/or absorbability in blood of a poorly water-soluble or water insoluble tetracyc…
USPTO Abstract
A composition which comprises substance represented by Formula (I), (see formula I) a pharmaceutically acceptable carrier, and a dissolution aid useful for improving solubility, oral absorbability and/or absorbability in blood of a poorly water-soluble or water insoluble tetracyclic compounds having an ALK inhibitory activity that are useful as a prophylactic and/or therapeutic agent for cancer, depression, and cognitive function disorder.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.